MEGANANO DIAGNOSTICS INC.

Medtech · Private

Blood-based diagnostic test measuring T cell receptor (TCR) clonality in CD8+ T cells to detect Alzheimer's disease and mild cognitive impairment

Grants
$483K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · The development of an RT-qPCR Assay for early diagnosis of Alzheimer's Disease$483,346
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1144ALGOMETRX INC—$1.9M
1145SS Innovations International, Inc.—$22M
1146VeinSound, Inc.—$100K
1147MEGANANO DIAGNOSTICS INC.——
1148CoastalOceanVision, Inc——
1149Orpyx Medical Technologies Inc.—$367K
1150Valisure—$9.8M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Kits And Methods For Diagnosis Of Neurological Diseasesapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.